Company / Operating Margin
aTYR PHARMA INC Operating Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-40856.3%
FY2025
5-year range
-40856.3% / -152.2%
FY2021-FY2025
Trend
-41.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -152.2% to -40856.3% over the past 3 years.
Based on SEC 10-K filings.
-40856.3% in FY2025 with a 5-year CAGR of -33079.1%.
Declined from -152.2% to -40856.3% over the past 3 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -40704.1pp
- 5-Year Change
- -33079.1pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin decreased 41.4% year-over-year.
- Peak operating margin was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -40856.3% | -41.4% |
| FY2024 | -28899.6% | - |
| FY2023 | - | - |
| FY2022 | -152.2% | +97.2% |
| FY2021 | -5445.0% | +30.0% |
| FY2020 | -7777.2% | +30.4% |
| FY2019 | -11171.8% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026